| Literature DB >> 35270408 |
Abstract
As the most important global news distributors, the big three international news agencies' reports about COVID-19 vaccines have a great influence on people's understanding of them. Based on the health belief model (HBM), we examined which constructs in the HBM were related to audiences' Twitter engagement and the differences among the agencies. We content-analyzed 1162 COVID-19 vaccine-related tweets from three international news agencies' Twitter accounts (@AFPespanol, @AP, @Reuters) from 2 December 2020 to 31 January 2021. The results showed that the most-used HBM construct was barriers, followed by benefits, susceptibility, cues to action, severity, and self-efficacy. About half of the tweets used a positive tone and nearly half of the tweets used a neutral tone, while only 3.1% of the tweets used a negative tone. Reuters used a significantly more negative tone, more neutral tone, and less positive tone than was expected. AFP used a significantly more positive tone and less neutral tone than was expected. The effectiveness of utilizing HBM constructs for vaccination promotion strongly depends on the audience context. The use of HBM constructs for vaccination was generally effective for Reuters but seems to have backfired for AFP.Entities:
Keywords: COVID-19; COVID-19 vaccine; Twitter; content analysis; health belief model (HBM)
Mesh:
Substances:
Year: 2022 PMID: 35270408 PMCID: PMC8910090 DOI: 10.3390/ijerph19052716
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Operational definitions and examples.
| HBM Constructs | Operational Definition | Themes | Examples |
|---|---|---|---|
| HBM Constructs>Susceptibility | Define population(s) at risk, risk levels; personalize risk based on a person’s features or behavior; heighten perceived susceptibility if too low. | 1.1 Susceptibility of the general public | Since the beginning of the pandemic, Latin America has become a hotspot for the virus. Mexico has reported 1,350,079 confirmed cases, Chile has 594,152 confirmed cases, and Costa Rica has 162,990 confirmed cases. |
| 1.2 Susceptibility of vulnerable people (e.g., older adults, medical staff) | In California, where health care workers will be among the first to be vaccinated, state health officials are prioritizing hospitals that have adequate storage capacity, serve high-risk populations and have the ability to vaccinate people quickly. | ||
| Severity | Specify consequences of the risk and the condition. | 2.1. Severity of the general public | The scourge has claimed more than 312,000 U.S. lives and killed 1.7 million people worldwide. New cases in the U.S. are running at over 216,000 per day on average. Deaths per day have hit all-time highs, eclipsing 3600 on Wednesday. |
| 2.2. Severity of vulnerable people (e.g., older adults, medical staff) | Public health data show that nationwide, more than 17,000 COVID-related deaths occurred in nursing homes, and 93% of all deaths from COVID-19 were over 65 years of age. | ||
| Self-efficacy | Provide training, guidance in performing action. | How quickly do I need a second COVID-19 vaccine shot? The first COVID-19 vaccines in the U.S. require two doses a few weeks apart. | |
| Benefits | Specify the efficacy of the advised action to reduce risk or seriousness of impact. | 4.1. Vaccines are effective at preventing COVID-19 for individuals | It added that the vaccine’s efficacy in preventing COVID-19 was 95 percent, worked uniformly across age groups, genders, and racial groups, as well as people with underlying conditions who are at high risk. |
| 4.2. Vaccines are NOT effective at preventing COVID-19 for individuals | However, they were significantly less effective at preventing COVID-19 in trial participants in South Africa, where the potent new variant is widespread, compared with countries in which this mutation is still rare, according to preliminary data released by the companies. | ||
| 4.3. The benefits of vaccination to society | German travel giant TUI on Thursday posted an annual loss of more than three billion euros as the pandemic devastated tourism, but the group said it was optimistic vaccines would boost travel demand in 2021. | ||
| Barriers | Specify the tangible and psychological costs of the advised action. | 5.1. Belief barriers (do not catch COVID-19 easily; have a strong immune system.) | He said he was not in a hurry to receive the vaccination. Estefs said: “I have been at home for a year and a half, and I can stay for another two or three months without any problems.” |
| 5.2. Harm barriers (COVID-19 vaccines can cause more harm than good; Side effects of the vaccine are serious) | “There is not enough research. It is too much too soon. Women are smarter. Men are going to just jump on whatever, they just don’t think. Women are more careful. We are thinking about the future, about side effects about not being sure if it’s safe.” | ||
| 5.3. Access Barriers (Unavailability of the vaccine in the right place and time; Cost of the vaccine is a set back) | Karen Stachowiak, a first-grade teacher in the Buffalo area, spent almost five hours on the state hot line and website to land an appointment for Wednesday, only to be told it was canceled. The Erie County Health Department said it scratched vaccinations for over 8000 people in the past few days because of inadequate supply. | ||
| Cues to Action | Specify the strategies to activate “readiness.” | 6.1. Government’s recommendation | The federal government is seeking to blunt such attitudes with a USD 250 million ad campaign set to roll out this week that will eventually target healthcare workers and vulnerable groups. The pitch touts how vaccines will help beat COVID-19 the same way they defeated smallpox, measles and polio. |
| 6.2. Experts’ recommendation | At the Tribhuvan University Teaching Hospital in Kathmandu, doctors were encouraging hesitant colleagues to get the vaccine. | ||
| 6.3. Testimony of celebrities | Like Vice President Mike Pence Friday and President-elect Joe Biden Monday, the highly visible officials received their vaccinations in a live event to inspire public confidence in the new coronavirus vaccines. | ||
| 6.4. Testimony of ordinary people | “I feel so privileged to be the first person vaccinated against COVID-19,” said Keenan, who wore a surgical mask and blue. |
Subthemes within the benefits theme.
| Themes | Sub-Themes |
|---|---|
| 4.1. Vaccines are effective at preventing COVID-19 for individuals | 4.1.1 Chinese vaccines are effective |
| 4.1.2 American vaccines are effective | |
| 4.1.3 British vaccines are effective | |
| 4.1.4 Russian vaccines are effective | |
| 4.1.5 Indian vaccines are effective | |
| 4.2. Vaccines are NOT effective at preventing COVID-19 for individuals | 4.2.1 Chinese vaccines are not effective |
| 4.2.2 American vaccines are not effective | |
| 4.2.3 British vaccines are not effective | |
| 4.2.4 Russian vaccines are not effective | |
| 4.2.5 Indian vaccines are not effective |
Descriptive statistics.
| Variables | n (%) |
|---|---|
| Health belief model constructs | |
| 1. Susceptibility | 325 (28) |
| 2. Severity | 231 (19.9) |
| 3. Self-efficacy | 25 (2.2) |
| 4. Benefits | 359 (30.9) |
| 5. Barriers | 684 (58.9) |
| 6. Cues to action | 248 (21.3) |
| Sub-themes of susceptibility | |
| 1.1. General public | 129 (11.1) |
| 1.2. Vulnerable people | 245 (21.1) |
| Sub-themes of severity | |
| 2.1. General public | 224 (19.3) |
| 2.2. Vulnerable people | 12 (1.0) |
| Sub-themes of benefits | |
| 4.1. Vaccines are effective at preventing COVID-19 for individuals | 359 (30.9) |
| 4.1.1. Chinese vaccines are effective | 33 (2.8) |
| 4.1.2. American vaccines are effective | 206 (17.7) |
| 4.1.3. British vaccines are effective | 69 (5.9) |
| 4.1.4. Russian vaccines are effective | 14 (1.2) |
| 4.1.5. Indian vaccines are effective | 15 (1.3) |
| 4.2. Vaccines are NOT effective at preventing COVID-19 for individuals | 11 (.9) |
| 4.2.1. Chinese vaccines are NOT effective | 7 (.6) |
| 4.2.2. American vaccines are NOT effective | 6 (.5) |
| 4.2.3. British vaccines are NOT effective | 0 (0) |
| 4.2.4. Russian vaccines are NOT effective | 2 (.2) |
| 4.2.5. Indian vaccines are NOT effective | 0 (0) |
| 4.3. The benefits of vaccination to society | 20 (1.7) |
| 4.4. Vaccines are NOT effective at preventing COVID-19 in society | 1 (.1) |
| Sub-themes of barriers | |
| 5.1. Belief barriers | 17 (1.5) |
| 5.2. Harm barriers | 62 (5.3) |
| 5.3. Access barriers | 184 (15.8) |
| Sub-themes of cues to action | |
| 6.1. Government’s recommendation | 14 (1.2) |
| 6.2. Experts’ recommendations | 25 (2.2) |
| 6.3. Testimony of celebrities | 101 (8.7) |
| 6.4. Testimony of ordinary people | 114 (9.8) |
| Sentiment regarding COVID-19 vaccines | |
| 7.1 Pro-vaccine | 564 (48.5) |
| 7.2 Anti-vaccine | 36 (3.1) |
| 7.3 Not mentioned | 562 (48.4) |
The frequency of HBM constructs used by three news agencies.
| Susceptibility | Severity | Self-Efficacy | Benefits | Barriers | Cues to Action | |
|---|---|---|---|---|---|---|
| AP | 59 (42.4) | 63 (45.3) | 5 (3.6) | 51 (36.7) | 101 (72.7) | 33 (23.7) |
| AFP | 114 (25.4) | 81 (18.0) | 11 (2.4) | 170 (37.9) | 285 (63.5) | 126 (28.1) |
| Reuters | 152 (26.5) | 87 (15.2) | 9 (1.6) | 138 (24.0) | 298 (51.9) | 89 (15.5) |
| Chi-square | 16.57 *** | 65.49 *** | 2.50 | 25.02 *** | 26.31 *** | 24.20 *** |
| df | 2 | 2 | 2 | 2 | 2 | 2 |
|
| 0.00 | 0.00 | 0.29 | 0.00 | 0.00 | 0.00 |
Note: Values inside the parenthesis represent the percentage of n. *** p < 0.001.
Figure 1The mean number of retweets and likes in the three news agencies’ Twitter accounts.
Figure 2The median number of retweets and likes in the three news agencies’ Twitter accounts.
HBM constructs and Twitter engagement.
| HBM Variable | Engagement Variables | Mean Ranks of the Group with the HBM Variable Present | Mean Ranks of the Group with the HBM Variable Absent | Mann–Whitney U | Z |
| |
|---|---|---|---|---|---|---|---|
| AP | Susceptibility | Retweets | 62.36 | 75.63 | 1909.50 | −1.92 | 0.06 |
| Likes | 63.58 | 74.74 | 1981.00 | −1.62 | 0.11 | ||
| Severity | Retweets | 73.79 | 66.86 | 2155.00 | −1.01 | 0.31 | |
| Likes | 73.16 | 67.38 | 2195.00 | −0.84 | 0.40 | ||
| Self-efficacy | Retweets | 54.10 | 70.59 | 255.50 | −0.90 | 0.37 | |
| Likes | 42.40 | 71.03 | 197.00 | −1.56 | 0.12 | ||
| Benefits | Retweets | 75.49 | 66.82 | 1964.00 | −1.22 | 0.22 | |
| Likes | 78.46 | 65.10 | 1812.50 | −1.89 | 0.06 | ||
| Barriers | Retweets | 72.61 | 63.07 | 1655.50 | −1.25 | 0.21 | |
| Likes | 73.18 | 61.54 | 1597.50 | −1.52 | 0.13 | ||
| Cues to action | Retweets | 77.71 | 67.60 | 1494.50 | −1.26 | 0.21 | |
| Likes | 83.39 | 65.83 | 1307.00 * | −2.19 | 0.03 | ||
| AFP | Susceptibility | Retweets | 170.00 | 243.71 | 12,825.50 *** | −5.24 | 0.00 |
| Likes | 182.58 | 239.44 | 14,259.00 *** | −4.04 | 0.00 | ||
| Severity | Retweets | 160.62 | 239.17 | 9689.00 *** | −4.93 | 0.00 | |
| Likes | 164.59 | 238.30 | 10,011.00 *** | −4.63 | 0.00 | ||
| Self-efficacy | Retweets | 312.14 | 222.81 | 1450.50 * | −2.26 | 0.02 | |
| Likes | 306.86 | 222.94 | 1508.50 * | −2.12 | 0.03 | ||
| Benefits | Retweets | 220.37 | 227.82 | 22,928.50 | −0.59 | 0.56 | |
| Likes | 223.54 | 225.89 | 23,466.50 | −0.19 | 0.85 | ||
| Barriers | Retweets | 223.86 | 226.98 | 23,046.00 | −0.25 | 0.81 | |
| Likes | 222.24 | 229.80 | 22,582.00 | −0.60 | 0.55 | ||
| Cues to action | Retweets | 189.98 | 238.66 | 15,936.50 *** | −3.57 | 0.00 | |
| Likes | 210.46 | 230.67 | 18,517.00 | −1.48 | 0.14 | ||
| Reuters | Susceptibility | Retweets | 310.32 | 279.28 | 28,603.50 * | −1.98 | 0.048 |
| Likes | 326.90 | 273.31 | 26,082.50 *** | −3.42 | 0.00 | ||
| Severity | Retweets | 317.58 | 282.13 | 18,567.50 | −1.84 | 0.07 | |
| Likes | 330.87 | 279.75 | 17,411.00 ** | −2.65 | 0.008 | ||
| Self-efficacy | Retweets | 189.94 | 289.05 | 1664.50 | −1.78 | 0.08 | |
| Likes | 151.61 | 289.66 | 1319.50 * | −2.48 | 0.01 | ||
| Benefits | Retweets | 311.45 | 279.92 | 26,779.50 | −1.95 | 0.05 | |
| Likes | 314.42 | 278.98 | 26,368.50 * | −2.19 | 0.03 | ||
| Barriers | Retweets | 312.28 | 260.74 | 33,738.50 *** | −3.72 | 0.00 | |
| Likes | 312.30 | 260.73 | 33,734.50 *** | −3.72 | 0.00 | ||
| Cues to action | Retweets | 325.48 | 280.53 | 18,202.00 * | −2.35 | 0.02 | |
| Likes | 351.85 | 275.69 | 15,855.50 *** | −3.98 | 0.00 |
* p < 0.05, ** p < 0.01, *** p < 0.001.
Sub-themes and Twitter engagement.
| HBM Variable | Engagement Variables | Mean Ranks of the Group with the HBM Variable Present | Mean Ranks of the Group with the HBM Variable Absent | Mann–Whitney U | Z |
| |
|---|---|---|---|---|---|---|---|
| AP | 4.1.1. Chinese vaccines are effective | Retweets | 29.83 | 72.78 | 223.50 ** | −3.09 | 0.00 |
| Likes | 27.44 | 72.95 | 202.00 *** | −3.28 | 0.00 | ||
| 4.1.2. American vaccines are effective | Retweets | 207.22 | 229.46 | 1251.50 | −1.96 | 0.05 | |
| Likes | 85.62 | 65.70 | 1166.50 * | −2.40 | 0.02 | ||
| 5.3. Access barriers | Retweets | 61.53 | 73.31 | 1619.50 | −1.55 | 0.12 | |
| Likes | 55.46 | 75.67 | 1383.00 ** | −2.66 | 0.008 | ||
| AFP | 1.1. Susceptibility of the general public | Retweets | 163.74 | 233.20 | 7247.00 *** | −3.66 | 0.00 |
| Likes | 165.08 | 233.02 | 7318.00 *** | −3.58 | 0.00 | ||
| 1.2. Susceptibility of vulnerable people | Retweets | 168.32 | 236.55 | 9866.00 *** | −4.18 | 0.00 | |
| Likes | 188.80 | 232.38 | 11,422.50 ** | −2.67 | 0.00 | ||
| 2.1. Severity of the general public | Retweets | 160.62 | 239.17 | 9689.00 *** | −4.93 | 0.00 | |
| Likes | 164.59 | 238.30 | 10,011.00 *** | −4.63 | 0.00 | ||
| 4.3. The benefits of vaccination to society | Retweets | 62.00 | 226.10 | 180.00 * | −2.18 | 0.03 | |
| Likes | 226.01 | 74.50 | 217.50 * | −2.02 | 0.04 | ||
| 5.2. Harm barriers | Retweets | 134.03 | 228.14 | 18,950.50 ** | −2.76 | 0.006 | |
| Likes | 126.23 | 228.41 | 1773.50 ** | −3.00 | 0.003 | ||
| 5.3. Access barriers | Retweets | 214.61 | 226.85 | 12,247.50 | −0.72 | 0.47 | |
| Likes | 190.42 | 231.17 | 10,602.50 * | −2.39 | 0.02 | ||
| 6.4. Testimony of ordinary people | Retweets | 188.77 | 230.48 | 9367.50 * | −2.30 | 0.02 | |
| Likes | 208.70 | 227.47 | 10,543.50 | −1.04 | 0.30 | ||
| Reuters | 1.1. Susceptibility of the general public | Retweets | 336.46 | 281.68 | 12,660 * | −2.44 | 0.02 |
| Likes | 343.40 | 280.85 | 12,236.50 ** | −2.79 | 0.005 | ||
| 1.2. Susceptibility of vulnerable people | Retweets | 299.60 | 284.53 | 24,679.00 | −0.87 | 0.39 | |
| Likes | 324.68 | 278.39 | 21,845.50 ** | −2.66 | 0.008 | ||
| 2.1. Severity of the general public | Retweets | 322.23 | 281.63 | 17,494.00 * | −2.06 | 0.04 | |
| Likes | 337.69 | 279.02 | 16,211.00 ** | −2.98 | 0.003 | ||
| 4.1. Vaccines are effective at preventing COVID-19 for individuals | Retweets | 311.45 | 279.92 | 26,779.50 | −1.95 | 0.05 | |
| Likes | 314.42 | 278.98 | 26,368.50 * | −2.19 | 0.03 | ||
| 4.1.2. American vaccines are effective | Retweets | 321.83 | 281.45 | 18,032.00 * | −2.08 | 0.04 | |
| Likes | 336.10 | 278.93 | 16,804.00 ** | −2.95 | 0.003 | ||
| 4.2. Vaccines are NOT effective at preventing COVID-19 for individuals | Retweets | 496.00 | 284.18 | 666.00 *** | −3.80 | 0.00 | |
| Likes | 379.17 | 286.04 | 1717.50 | −1.67 | 0.10 | ||
| 4.2.2. American vaccines are NOT effective | Retweets | 505.40 | 285.59 | 333.00 ** | −2.95 | 0.003 | |
| Likes | 428.30 | 286.26 | 718.50 | −1.91 | 0.06 | ||
| 4.3. The benefits of vaccination to society | Retweets | 123.94 | 292.49 | 1954.00 *** | −4.13 | 0.00 | |
| Likes | 108.62 | 292.96 | 1693.50 *** | −4.52 | 0.00 | ||
| 5.2. Harm barriers | Retweets | 346.70 | 282.95 | 8499.50 * | −2.37 | 0.02 | |
| Likes | 310.30 | 285.75 | 9991.50 | −0.91 | 0.36 | ||
| 5.3. Access barriers | Retweets | 244.34 | 294.19 | 15,811.50 * | −2.45 | 0.014 | |
| Likes | 231.56 | 296.17 | 14,827.00 *** | −3.18 | 0.00 | ||
| 6.3. Testimony of celebrities | Retweets | 375.18 | 281.11 | 7013.00 *** | −3.42 | 0.00 | |
| Likes | 396.26 | 279.57 | 6191.00 *** | −4.24 | 0.00 |
* p < 0.05, ** p < 0.01, *** p < 0.001.
News agencies’ sentiments regarding COVID-19 vaccines.
| Sentiment | AP | AFP | Reuters | Chi-Square | df |
| Total Sample |
|---|---|---|---|---|---|---|---|
| Positive | 71 (51.1) | 246 (54.8) | 247 (43.0) | 14.35 *** | 2 | 0.00 | 564 (48.5) |
| Negative | 2 (1.4) | 8 (1.8) | 26 (4.5) | 7.78 * | 2 | 0.02 | 36 (3.1) |
| Neutral | 66 (47.5) | 195 (43.4) | 301 (52.4) | 8.24 * | 2 | 0.02 | 562 (48.4) |
* p < 0.05, *** p < 0.001.
Tweets’ sentiments regarding COVID-19 vaccines and Twitter engagement by news agencies.
| Engagement Variables | Sentiment | Mean Rank of the Engagement Variable | Kruskal–Wallis H | df |
| |
|---|---|---|---|---|---|---|
| AP | Retweets | Positive | 76.61 | |||
| Negative | 93.00 | |||||
| Neutral | 62.20 | |||||
| Overall model | 5.04 | 2 | 0.08 | |||
| Likes | Positive | 78.08 | ||||
| Negative | 86.50 | |||||
| Neutral | 60.80 | |||||
| Overall model | 6.64 * | 2 | 0.04 | |||
| AFP | Retweets | Positive | 223.19 | |||
| Negative | 299.81 | |||||
| Neutral | 224.21 | |||||
| Overall model | 2.72 | 2 | 0.26 | |||
| Likes | Positive | 227.09 | ||||
| Negative | 254.25 | |||||
| Neutral | 221.17 | |||||
| Overall model | 0.64 | 2 | 0.73 | |||
| Reuters | Retweets | Positive | 297.77 | |||
| Negative | 339.27 | |||||
| Neutral | 274.60 | |||||
| Overall model | 5.30 | 2 | 0.07 | |||
| Likes | Positive | 310.50 | ||||
| Negative | 270.17 | |||||
| Neutral | 270.12 | |||||
| Overall model | 8.34 * | 2 | 0.02 |
* p < 0.05.